A Dose Selection Trial of CKD-330 in Patients With Essential Hypertension

PHASE2UnknownINTERVENTIONAL

Enrollment

456

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

April 30, 2015

Study Completion Date

June 30, 2015

Conditions

Essential Hypertension

Interventions

DRUG

Candesartan 8mg

Once a day, 8 weeks

DRUG

Candesartan 16mg

Once a day, 8 weeks

DRUG

Amlodipine 5mg

Once a day, 8 weeks

DRUG

Amlodipine 10mg

Once a day, 8 weeks

Trial Locations (1)

RECRUITING

Seoul National University Bundang Hospital, Seongnam